A murine–human chimeric IgG antibody against vascular endothelial growth factor receptor 2 inhibits angiogenesis in vitro
Authors:
Open Access
- 24 July 2013
- journal article
- Published by Springer Nature in Cytotechnology
- Vol. 66 (3) , 395-411
Abstract
The online version of this article (doi:10.1007/s10616-013-9587-x) contains supplementary material, which is available to authorized users.Keywords
This publication has 40 references indexed in Scilit:
- Inhibition of Lymphangiogenesis and Angiogenesis in Breast Tumor Xenografts and Lymph Nodes by a Peptide Derived from Transmembrane Protein 45ANeoplasia, 2013
- Protective Actions of Globular and Full-Length Adiponectin on Human Endothelial Cells: Novel Insights into Adiponectin-Induced AngiogenesisJournal of Vascular Research, 2012
- In Vitro and In Vivo Anti-Angiogenic Activities of Panduratin APLOS ONE, 2012
- A Human Fab-Based Immunoconjugate Specific for the LMP1 Extracellular Domain Inhibits Nasopharyngeal Carcinoma Growth In Vitro and In VivoMolecular Cancer Therapeutics, 2012
- VEGF is essential for the growth and migration of human hepatocellular carcinoma cellsMolecular Biology Reports, 2011
- Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascitesInternational Journal of Cancer, 2011
- Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ3Blood, 2011
- Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacyProceedings of the National Academy of Sciences, 2011
- VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and FutureCurrent Cancer Drug Targets, 2011
- Humanization of Predicted T-Cell Epitopes Reduces the Immunogenicity of Chimeric Antibodies: New Evidence Supporting a Simple MethodHybridoma and Hybridomics, 2003